BBB Therapeutics is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs with BBB Therapeutics' proprietary G-TechnologyÂŽ for enhanced drug delivery across the blood-brain barrier.
BBB Therapeutics currently has two products in clinical trials: its lead product 2B3-101 is in a Phase IIa trial in Europe and the US for the treatment of primary brain tumors as well as brain metastases; the second product 2B3-201 for MS relapses and other neuroinflammatory diseases is completing a Phase I clinical study.
Company Details
- Employees
- 21
- Founded
- -
- Address
- J.h. Oortweg 19, Leiden,2333 Ch,netherlands
- Industry
- Biotechnology
- Website
- bbbtherapeutics.com
- HQ
- Leiden
Bbb Therapeutics Questions
Bbb Therapeutics's website is bbbtherapeutics.com
Bbb Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/to-bbb
Bbb Therapeutics has
21 employees.
View email and phone details for 21
employees at Bbb Therapeutics.
Bbb Therapeutics's industry is
Biotechnology
Bbb Therapeutics's top competitors are
Biotech Booster,
Medi-Fill,mixing,filling And Packing Bv,
Obelisc,
2-Bbb Medicines Bv,
Sapreme Technologies Bv,
Pharmahelder B.v.,
Multifund,
Sop Consultancy,
Ubiq,
Cellcotec.
Bbb Therapeutics's categories are Biotechnology
Bbb Therapeutics's founding year is 2003
